Guggenheim analyst Yatin Suneja initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $100.
Guggenheim Initiates Coverage On Q32 Bio With Buy Rating, Announces Price Target of $100
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.